Immunomodulation.
In keeping with clinical data, a significant but transient immunomodulation of B and T lymphocytes was observed in children but not in adults in the first 3–6 months after BM-MSC administration, despite concomitant tapering of immunosuppression, suggesting the possibility of a direct immunomodulatory effect of infused autologous BM-MSCs (